Suresh Sundram
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Suresh Sundram has a total of 484 co-authors. Here are the top co-authors by number of shared publications:
- Brian Dean
Department of Psychiatry, The University of Melbourne
15 shared publications - Christos Pantelis
The University of Melbourne
13 shared publications Avril Pereira
The Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Australia
11 shared publications- Chad A. Bousman
University of Calgary
8 shared publications - Debbie C. Hocking
Department of Psychiatry, School of Clinical Sciences, Monash University, Clayton, VIC, Australia
8 shared publications - Jason Bruggemann
School of Psychiatry, University of New South Wales, Sydney, Australia; Neuroscience Research Australia, Sydney, Australia
6 shared publications
Latest Publications
- 2 November 2026
- Published by SAGE Publications in Australasian Psychiatry
The quiet end of the spectrum: A case report and review of “simple schizophrenia”
Background: Schizophrenia is increasingly understood as a neurodevelopmental disorder in which cognitive and negative symptoms may precede or overshadow florid psychosis. Such neuropsychiatric presentations can be difficult to recognise within current diagnostic frameworks that privilege positive symptoms. Objective: To illustrate a schizophrenia presentation without hallucinations and delusions and to contextualise it within contemporary and historical nosology. Methods: Single case report with a focussed narrative review of the literature on simple schizophrenia subtypes. Case: a 24-year-old woman experienced a two-year insidious decline in motivation, social engagement, and cognition, with prominent affective flattening, avolition, bradyphrenia, poverty of speech, and psychomotor slowing. There were no delusions or hallucinations, and thought form was linear. Extensive investigations including MRI, EEG, FDG-PET, and CSF studies were unremarkable. Neuropsychological testing showed deficits in new learning, processing speed, and executive functioning consistent with schizophrenia-spectrum illness. The illness was refractory to multiple antidepressants, antipsychotics, and a course of electroconvulsive therapy. Following exclusion of organic pathology, multidisciplinary assessment, and longitudinal review, a diagnosis of schizophrenia was formulated. Conclusion: Current diagnostic systems may overlook individuals with schizophrenia without hallucinations or delusions. Incorporating neuropsychiatric markers and establishing cognitive trajectories into diagnostic thinking may enable earlier identification and more targeted interventions.
- 2 November 2026
- Published by SAGE Publications in Australasian Psychiatry
The quiet end of the spectrum: A case report and review of “simple schizophrenia”
Background: Schizophrenia is increasingly understood as a neurodevelopmental disorder in which cognitive and negative symptoms may precede or overshadow florid psychosis. Such neuropsychiatric presentations can be difficult to recognise within current diagnostic frameworks that privilege positive symptoms. Objective: To illustrate a schizophrenia presentation without hallucinations and delusions and to contextualise it within contemporary and historical nosology. Methods: Single case report with a focussed narrative review of the literature on simple schizophrenia subtypes. Case: a 24-year-old woman experienced a two-year insidious decline in motivation, social engagement, and cognition, with prominent affective flattening, avolition, bradyphrenia, poverty of speech, and psychomotor slowing. There were no delusions or hallucinations, and thought form was linear. Extensive investigations including MRI, EEG, FDG-PET, and CSF studies were unremarkable. Neuropsychological testing showed deficits in new learning, processing speed, and executive functioning consistent with schizophrenia-spectrum illness. The illness was refractory to multiple antidepressants, antipsychotics, and a course of electroconvulsive therapy. Following exclusion of organic pathology, multidisciplinary assessment, and longitudinal review, a diagnosis of schizophrenia was formulated. Conclusion: Current diagnostic systems may overlook individuals with schizophrenia without hallucinations or delusions. Incorporating neuropsychiatric markers and establishing cognitive trajectories into diagnostic thinking may enable earlier identification and more targeted interventions.
- 25 December 2025
- Published by SAGE Publications in International Journal of Social Psychiatry
Validation of the Italian Version of the STAR-MH Mental Health Screening Tool in a Sample of Asylum Seekers and Refugees in Northern Italy
Background: Asylum seekers and refugees (ASR) are at high risk of mental health disorders including posttraumatic stress disorder (PTSD), major depressive disorder (MDD), and anxiety. However, prevalence rates vary significantly due to methodological differences and the diverse socio-demographic characteristics of these populations. Access to mental health care is further complicated by language barriers, cultural differences, and systemic discrimination. The STAR-MH (Screening Tool for Asylum-seeker and Refugee Mental Health) was developed in the original version as a brief, easy-to-administer tool for early detection of MDD and PTSD in this vulnerable group. Objective: To standardise the Italian version of the STAR-MH for use in non-clinical contexts, such as migrant reception centres. Methods: The English version of the STAR-MH was back-translated into Italian following WHO guidelines; the resulting tool was then tested on a sample of 122 adult ASR in Northern Italy residing in migrant reception centres. Psychometric evaluations included internal consistency (Cronbach’s α), factorial validity (PCA analysis), and construct validity (correlations with standardised psychiatric assessment tools such as the HSCL-25, HTQ-5, and MINI). ROC analyses were run to test its diagnostic properties and derive its cut-off score. Results: The Italian version of the STAR-MH showed sufficient, albeit sub-optimal, internal consistency (Cronbach’s α = .68) and a mono-component structure. While it was not sufficiently sensitive to MDD (which may be attributed to content- and culture-related biases), it demonstrated strong convergent validity with established psychiatric assessment tools and high diagnostic accuracy for PTSD (AUC = 0.82, sensitivity = 80%, and specificity = 76.7%). Conclusion: The Italian version of the STAR-MH is a clinimetrically sound instrument to screen for PTSD among ASR, although modifications may be needed to improve its ability to capture MDD in different ASR populations. As it is, the STAR-MH can be a valuable resource for non healthcare providers, such as frontline workers, to facilitate timely mental health interventions.
- 25 December 2025
- Published by SAGE Publications in International Journal of Social Psychiatry
Validation of the Italian Version of the STAR-MH Mental Health Screening Tool in a Sample of Asylum Seekers and Refugees in Northern Italy
Background: Asylum seekers and refugees (ASR) are at high risk of mental health disorders including posttraumatic stress disorder (PTSD), major depressive disorder (MDD), and anxiety. However, prevalence rates vary significantly due to methodological differences and the diverse socio-demographic characteristics of these populations. Access to mental health care is further complicated by language barriers, cultural differences, and systemic discrimination. The STAR-MH (Screening Tool for Asylum-seeker and Refugee Mental Health) was developed in the original version as a brief, easy-to-administer tool for early detection of MDD and PTSD in this vulnerable group. Objective: To standardise the Italian version of the STAR-MH for use in non-clinical contexts, such as migrant reception centres. Methods: The English version of the STAR-MH was back-translated into Italian following WHO guidelines; the resulting tool was then tested on a sample of 122 adult ASR in Northern Italy residing in migrant reception centres. Psychometric evaluations included internal consistency (Cronbach’s α), factorial validity (PCA analysis), and construct validity (correlations with standardised psychiatric assessment tools such as the HSCL-25, HTQ-5, and MINI). ROC analyses were run to test its diagnostic properties and derive its cut-off score. Results: The Italian version of the STAR-MH showed sufficient, albeit sub-optimal, internal consistency (Cronbach’s α = .68) and a mono-component structure. While it was not sufficiently sensitive to MDD (which may be attributed to content- and culture-related biases), it demonstrated strong convergent validity with established psychiatric assessment tools and high diagnostic accuracy for PTSD (AUC = 0.82, sensitivity = 80%, and specificity = 76.7%). Conclusion: The Italian version of the STAR-MH is a clinimetrically sound instrument to screen for PTSD among ASR, although modifications may be needed to improve its ability to capture MDD in different ASR populations. As it is, the STAR-MH can be a valuable resource for non healthcare providers, such as frontline workers, to facilitate timely mental health interventions.
- Open Access
- 29 October 2025
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 5 (10) , e0005196
A systematic review of qualitative research on the physical and mental health impacts of immigration detention on asylum seekers and refugees
Globally, the number of refugees and asylum seekers has reached unprecedented levels, prompting many host countries to adopt immigration detention as a strategy to deter unauthorised arrivals. While previous studies have largely used quantitative methods to examine the consequences of detention, this is the first qualitative systematic review synthesising evidence on the impact of immigration detention on the mental and physical health of adult and child asylum seekers and refugees (ASR) in middle- to high-income host countries. A systematic search of medical, allied health, and social science databases and grey literature was conducted between December 2021 and October 2024 (Embase, MEDLINE, PsycINFO, CINAHL Plus, Global Health, APA PsycARTICLES, Social Policy and Practice, Cochrane Library, Scopus, and Open Grey). Reference lists of included studies were also screened. The review was registered with PROSPERO (CRD42022328867). Study selection, critical appraisal, and data extraction were performed using the Joanna Briggs Institute Critical Appraisal Checklist for Qualitative Research. Of 2,512 records identified, 564 full texts were assessed, and 20 studies met the inclusion criteria, comprising 374 adults and 139 children with current or past detention experiences, with detention durations ranging from two weeks to 38 months. Thematic synthesis revealed five overarching themes: human rights violations within detention; systemic failures of healthcare provision and resultant vulnerability; adverse health impacts of detention; changes in self-concept, relationships, and worldview after release; and enduring negative consequences for mental and physical health. Findings highlight that immigration detention uniformly undermines the health and well-being of ASR, with effects persisting long after release. This review underscores the urgent need for health and human rights to be central considerations in migration policy and practice.
- 29 October 2025
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 5 (10) , e0005196
Open AccessA systematic review of qualitative research on the physical and mental health impacts of immigration detention on asylum seekers and refugees
Globally, the number of refugees and asylum seekers has reached unprecedented levels, prompting many host countries to adopt immigration detention as a strategy to deter unauthorised arrivals. While previous studies have largely used quantitative methods to examine the consequences of detention, this is the first qualitative systematic review synthesising evidence on the impact of immigration detention on the mental and physical health of adult and child asylum seekers and refugees (ASR) in middle- to high-income host countries. A systematic search of medical, allied health, and social science databases and grey literature was conducted between December 2021 and October 2024 (Embase, MEDLINE, PsycINFO, CINAHL Plus, Global Health, APA PsycARTICLES, Social Policy and Practice, Cochrane Library, Scopus, and Open Grey). Reference lists of included studies were also screened. The review was registered with PROSPERO (CRD42022328867). Study selection, critical appraisal, and data extraction were performed using the Joanna Briggs Institute Critical Appraisal Checklist for Qualitative Research. Of 2,512 records identified, 564 full texts were assessed, and 20 studies met the inclusion criteria, comprising 374 adults and 139 children with current or past detention experiences, with detention durations ranging from two weeks to 38 months. Thematic synthesis revealed five overarching themes: human rights violations within detention; systemic failures of healthcare provision and resultant vulnerability; adverse health impacts of detention; changes in self-concept, relationships, and worldview after release; and enduring negative consequences for mental and physical health. Findings highlight that immigration detention uniformly undermines the health and well-being of ASR, with effects persisting long after release. This review underscores the urgent need for health and human rights to be central considerations in migration policy and practice.
- Open Access
- 16 October 2025
- Published by Center for Open Science in PsyArXiv
Heightened affective reactivity is associated with more severe symptoms of emotional disorders
Disturbances of emotion are a core feature of psychological disorders generally, and of mood and anxiety disorders in particular. However, it remains unclear what specific patterns of affective disturbance are shared across different symptom domains. Here we examined correlations between emotional disorder symptom severity (anxiety, depression, hypomania, and anhedonia) and affective reactivity to gain and loss outcomes within a decision-making task with embedded sampling of emotional valence (Experiment 1: N = 329; preregistered replication in Experiment 2: N = 524). Using hierarchical Bayesian computational modelling of emotion self-reports, we found that greater affective reactivity to gains and losses within the task was associated with more severe symptoms of both anxiety and hypomania. This suggest that heightened reactivity to both appetitive and aversive outcomes indexes emotional disorder severity across multiple symptom domains of psychopathology, in line with theoretical frameworks that conceptualize affective disturbance as a generalized risk factor for psychopathology.
- 16 October 2025
- Published by Center for Open Science in PsyArXiv
Open AccessHeightened affective reactivity is associated with more severe symptoms of emotional disorders
Disturbances of emotion are a core feature of psychological disorders generally, and of mood and anxiety disorders in particular. However, it remains unclear what specific patterns of affective disturbance are shared across different symptom domains. Here we examined correlations between emotional disorder symptom severity (anxiety, depression, hypomania, and anhedonia) and affective reactivity to gain and loss outcomes within a decision-making task with embedded sampling of emotional valence (Experiment 1: N = 329; preregistered replication in Experiment 2: N = 524). Using hierarchical Bayesian computational modelling of emotion self-reports, we found that greater affective reactivity to gains and losses within the task was associated with more severe symptoms of both anxiety and hypomania. This suggest that heightened reactivity to both appetitive and aversive outcomes indexes emotional disorder severity across multiple symptom domains of psychopathology, in line with theoretical frameworks that conceptualize affective disturbance as a generalized risk factor for psychopathology.
- Open Access
- 27 August 2025
- Published by Springer Nature in European Child & Adolescent Psychiatry
- Vol. 35 (1) , 47-73
Immigration detention of children: a systematic review and meta-analysis of physical and mental health impacts
Upper-middle and high income countries employ immigration detention for asylum-seeking/refugee (ASR) children despite documented health risks. We sought to assess the physical and mental health impacts of detention on ASR children in these settings. A systematic review of 15 studies ( N = 4,890 children) from 2,512 screened records was undertaken. Relevant databases were searched from 1808 to October 2024 for papers using the search terms ‘unaccompanied/separated/children/minors/adolescents,’ and ‘war/trauma/asylum/refugee,’ and ‘mental illness/ PTSD/depression/ distress, depressive symptoms/ anxiety/physical health/ health/risk factors,’ as well as ‘detention/detain/imprison/incarcerate’. Joanna Briggs Institute tools assessed quality. Strengths and Difficulties Questionnaire (SDQ) data from three studies ( n = 239) underwent random-effects meta-analysis as the primary measure of social-emotional and behavioural issues. Duration of detention ranged from 2 weeks to 36 months. Prevalence of PTSD ranged from 6.5% (brief detention < 30 days) to 100% (prolonged detention ≥ 12 months). MDD was reported in 44–95% of children, and suicidal ideation/self-harm in 25–57%. Developmental delays were observed in 75% of children detained ≥ 12 months. Anxiety disorders (45–50%) included separation anxiety and generalised anxiety. The mixed model meta-analysis revealed severe mental health burdens with detained children exhibiting total difficulties scores twice the normative population mean (16.63 vs. 7.1–8.4, 95% CI: 11.19–22.07) with elevated subscale scores for emotional symptoms (5.40 vs. 1.6–2.1, 95% CI: 3.79–7.01), conduct problems (2.93 vs. 1.3–1.6, 95% CI: 1.53–4.32), and peer problems (3.34 vs. 1.4–1.6, 95% CI: 2.17–4.51) (I² >75% for all mental health outcomes). Physical health impacts included malnutrition (24–56%), dental caries (21–54%), vitamin D deficiency (51%), and somatic complaints (e.g., headaches, enuresis). Systemic risk factors—detention duration, family separation, and cumulative trauma—exacerbated harm, with parental mental illness (54%) and dehumanising conditions (e.g., numeric identification) amplifying risks. Comparative data highlight resettled children’s recovery trajectories when provided stability and community support. Most studies were cross-sectional, limiting the ability to assess causality. This review consolidates evidence that establishes a connection between immigration detention and the manifestation of mental disorders, categorising it as an instance of early-life adversity. All fifteen studies identified detrimental consequences, and a meta-analysis of three studies revealed significant emotional distress and behavioural issues. These findings underscore the urgent need for policy reforms to abolish prolonged detention, prioritise family unity, and implement trauma-informed care to mitigate irreversible health consequences for ASR children. Policymakers must recognise these impacts and refrain from detaining and separating children and families. Systematic review registration: https://www.crd.york.ac.uk/prospero/ , registration number CRD42022328867.
- 27 August 2025
- Published by Springer Nature in European Child & Adolescent Psychiatry
- Vol. 35 (1) , 47-73
Open AccessImmigration detention of children: a systematic review and meta-analysis of physical and mental health impacts
Upper-middle and high income countries employ immigration detention for asylum-seeking/refugee (ASR) children despite documented health risks. We sought to assess the physical and mental health impacts of detention on ASR children in these settings. A systematic review of 15 studies ( N = 4,890 children) from 2,512 screened records was undertaken. Relevant databases were searched from 1808 to October 2024 for papers using the search terms ‘unaccompanied/separated/children/minors/adolescents,’ and ‘war/trauma/asylum/refugee,’ and ‘mental illness/ PTSD/depression/ distress, depressive symptoms/ anxiety/physical health/ health/risk factors,’ as well as ‘detention/detain/imprison/incarcerate’. Joanna Briggs Institute tools assessed quality. Strengths and Difficulties Questionnaire (SDQ) data from three studies ( n = 239) underwent random-effects meta-analysis as the primary measure of social-emotional and behavioural issues. Duration of detention ranged from 2 weeks to 36 months. Prevalence of PTSD ranged from 6.5% (brief detention < 30 days) to 100% (prolonged detention ≥ 12 months). MDD was reported in 44–95% of children, and suicidal ideation/self-harm in 25–57%. Developmental delays were observed in 75% of children detained ≥ 12 months. Anxiety disorders (45–50%) included separation anxiety and generalised anxiety. The mixed model meta-analysis revealed severe mental health burdens with detained children exhibiting total difficulties scores twice the normative population mean (16.63 vs. 7.1–8.4, 95% CI: 11.19–22.07) with elevated subscale scores for emotional symptoms (5.40 vs. 1.6–2.1, 95% CI: 3.79–7.01), conduct problems (2.93 vs. 1.3–1.6, 95% CI: 1.53–4.32), and peer problems (3.34 vs. 1.4–1.6, 95% CI: 2.17–4.51) (I² >75% for all mental health outcomes). Physical health impacts included malnutrition (24–56%), dental caries (21–54%), vitamin D deficiency (51%), and somatic complaints (e.g., headaches, enuresis). Systemic risk factors—detention duration, family separation, and cumulative trauma—exacerbated harm, with parental mental illness (54%) and dehumanising conditions (e.g., numeric identification) amplifying risks. Comparative data highlight resettled children’s recovery trajectories when provided stability and community support. Most studies were cross-sectional, limiting the ability to assess causality. This review consolidates evidence that establishes a connection between immigration detention and the manifestation of mental disorders, categorising it as an instance of early-life adversity. All fifteen studies identified detrimental consequences, and a meta-analysis of three studies revealed significant emotional distress and behavioural issues. These findings underscore the urgent need for policy reforms to abolish prolonged detention, prioritise family unity, and implement trauma-informed care to mitigate irreversible health consequences for ASR children. Policymakers must recognise these impacts and refrain from detaining and separating children and families. Systematic review registration: https://www.crd.york.ac.uk/prospero/ , registration number CRD42022328867.
- Open Access
- 11 June 2025
- Published by SAGE Publications in Australasian Psychiatry
- Vol. 33 (4) , 769-770
Response to: RANZCP Position Statement 46: A missed opportunity to provide sophisticated guidance on asylum seeker and refugee policy
- 11 June 2025
- Published by SAGE Publications in Australasian Psychiatry
- Vol. 33 (4) , 769-770
Open AccessResponse to: RANZCP Position Statement 46: A missed opportunity to provide sophisticated guidance on asylum seeker and refugee policy
- Open Access
- 15 May 2025
- Published by Springer Nature in Neuropsychopharmacology
- Vol. 50 (13) , 1938-1948
Effects of NMDA receptor antagonists on working memory and gamma oscillations, and the mediating role of the GluN2D subunit
Working memory relies on synchronised network oscillations involving complex interplay between pyramidal cells and GABAergic interneurons. NMDA receptor (NMDAR) antagonists influence both network oscillations and working memory, but the relationship between these two consequences has not been elucidated. This study aimed to determine the effect of NMDAR antagonists on network oscillations during a working memory task in mice, and the contribution of the GluN2D receptor subunit. After training wildtype (WT) and GluN2D-knockout (KO) mice on the Trial-Unique-Non-match to Location (TUNL) touchscreen task of working memory, recording electrodes were implanted into the prefrontal cortex (PFC) and hippocampus. Mice were challenged with either (S)-ketamine (30 mg/kg), (R)-ketamine (30 mg/kg), phencyclidine (PCP, 1 mg/kg), MK-801 (0.3 mg/kg) or saline prior to TUNL testing while simultaneous local field potential recordings were acquired. PCP disrupted working memory accuracy in WT ( p = 0.001) but not GluN2D-KO mice ( p = 0.79). MK-801 (p < 0.0001), (S)-ketamine (p < 0.0001) and (R)-ketamine ( p = 0.007) disrupted working memory accuracy in both genotypes. PCP increased baseline hippocampal gamma (30–80 Hz) power in WT ( p = 0.0015) but not GluN2D-KO mice ( p = 0.92). All drugs increased baseline gamma power in the PFC in both genotypes (p < 0.05). Low gamma was induced during the maintenance phase of the TUNL task and increased when mice correctly completed the task ( p = 0.024). This response-dependent increase in low gamma was disrupted by all drugs. In summary, PCP action involves the GluN2D subunit of the NMDA receptor in the hippocampus to alter baseline gamma power and working memory. Task-induced low gamma activity during maintenance aligns with task performance, and is disrupted by all NMDAR antagonists.
- 15 May 2025
- Published by Springer Nature in Neuropsychopharmacology
- Vol. 50 (13) , 1938-1948
Open AccessEffects of NMDA receptor antagonists on working memory and gamma oscillations, and the mediating role of the GluN2D subunit
Working memory relies on synchronised network oscillations involving complex interplay between pyramidal cells and GABAergic interneurons. NMDA receptor (NMDAR) antagonists influence both network oscillations and working memory, but the relationship between these two consequences has not been elucidated. This study aimed to determine the effect of NMDAR antagonists on network oscillations during a working memory task in mice, and the contribution of the GluN2D receptor subunit. After training wildtype (WT) and GluN2D-knockout (KO) mice on the Trial-Unique-Non-match to Location (TUNL) touchscreen task of working memory, recording electrodes were implanted into the prefrontal cortex (PFC) and hippocampus. Mice were challenged with either (S)-ketamine (30 mg/kg), (R)-ketamine (30 mg/kg), phencyclidine (PCP, 1 mg/kg), MK-801 (0.3 mg/kg) or saline prior to TUNL testing while simultaneous local field potential recordings were acquired. PCP disrupted working memory accuracy in WT ( p = 0.001) but not GluN2D-KO mice ( p = 0.79). MK-801 (p < 0.0001), (S)-ketamine (p < 0.0001) and (R)-ketamine ( p = 0.007) disrupted working memory accuracy in both genotypes. PCP increased baseline hippocampal gamma (30–80 Hz) power in WT ( p = 0.0015) but not GluN2D-KO mice ( p = 0.92). All drugs increased baseline gamma power in the PFC in both genotypes (p < 0.05). Low gamma was induced during the maintenance phase of the TUNL task and increased when mice correctly completed the task ( p = 0.024). This response-dependent increase in low gamma was disrupted by all drugs. In summary, PCP action involves the GluN2D subunit of the NMDA receptor in the hippocampus to alter baseline gamma power and working memory. Task-induced low gamma activity during maintenance aligns with task performance, and is disrupted by all NMDAR antagonists.
- Open Access
Australian immigration detention health study protocol: a prospective, mixed-methods cohort study examining the physical and mental health of refugees and asylum seekers
Introduction Globally, studies have consistently demonstrated the harmful mental and physical health impacts of immigration detention, with high levels of distress documented among detained asylum seekers and refugees (ASR). However, the consequences of immigration detention over time on the psychological and physical health of ASR are unclear and poorly quantified. Methods and analysis This prospective, mixed-methods cohort study will recurrently assess and describe the health profiles of adult ASR with an experience of Australian Government-sponsored immigration detention greater than 28 days. ASR ≥18 years old released from immigration detention will be assessed at 0, 3, 6 and 12 months and annually thereafter for up to 10 years, contingent on resourcing. Five self-report scales and a structured psychiatric interview will assess the primary outcome of depression, anxiety, post-traumatic stress, pain intensity and severity, somatic symptoms, functional impairment, physical health conditions associated with detention and engagement in available treatment of this cohort. Additionally, pre-existing health records will be accessed to identify current and previous health status and assess changes in these health indices. Quantitative findings will be triangulated with a qualitative phenomenological thematic analysis of interviews to determine additional psychosocial factors associated with the outcomes. Ethics and dissemination The study protocol was approved by the Monash Health Human Research Ethics Committee (HREC/73614/MonH-2021-251322). Results will be reported at conferences, in peer-reviewed publications and to all relevant stakeholder groups.
Open AccessAustralian immigration detention health study protocol: a prospective, mixed-methods cohort study examining the physical and mental health of refugees and asylum seekers
Introduction Globally, studies have consistently demonstrated the harmful mental and physical health impacts of immigration detention, with high levels of distress documented among detained asylum seekers and refugees (ASR). However, the consequences of immigration detention over time on the psychological and physical health of ASR are unclear and poorly quantified. Methods and analysis This prospective, mixed-methods cohort study will recurrently assess and describe the health profiles of adult ASR with an experience of Australian Government-sponsored immigration detention greater than 28 days. ASR ≥18 years old released from immigration detention will be assessed at 0, 3, 6 and 12 months and annually thereafter for up to 10 years, contingent on resourcing. Five self-report scales and a structured psychiatric interview will assess the primary outcome of depression, anxiety, post-traumatic stress, pain intensity and severity, somatic symptoms, functional impairment, physical health conditions associated with detention and engagement in available treatment of this cohort. Additionally, pre-existing health records will be accessed to identify current and previous health status and assess changes in these health indices. Quantitative findings will be triangulated with a qualitative phenomenological thematic analysis of interviews to determine additional psychosocial factors associated with the outcomes. Ethics and dissemination The study protocol was approved by the Monash Health Human Research Ethics Committee (HREC/73614/MonH-2021-251322). Results will be reported at conferences, in peer-reviewed publications and to all relevant stakeholder groups.
- Open Access
- 9 April 2025
- Published by Springer Nature in Schizophrenia
- Vol. 11 (1) , 1-9
Visual integration deficits associated with psychosis are independent of diagnosis
Evidence of altered visual processing is well‐established in schizophrenia. Visual integration deficits have been highlighted as a potential diagnostic biomarker to distinguish schizophrenia from other psychiatric disorders. Motivated by the current lack of cross-diagnostic assessments of visual integration performance, the current study used the Jittered Orientation Visual Integration (JOVI) task to assess contour integration performance in 85 psychiatric inpatients split into “schizophrenia spectrum” (n = 40) and “other psychiatric disorders” (n = 45), and healthy controls (n = 43). The study also examined attentional and working memory ability using the Digit Span Task. JOVI accuracy scores were found to be significantly impaired relative to healthy controls for both the schizophrenia (p < 0.001) and other psychiatric (p < 0001) patient groups. In line with a transdiagnostic deficit, no differences in JOVI accuracy were seen between the patient groups (p = 0.97) with reduced JOVI accuracy correlating with worsening psychosis regardless of diagnosis (r = −0.32, p < 0.05). Schizophrenia spectrum patients also showed reduced Digit Span Forward (p < 0.001) and Backward scores (p < 0.001). The other psychiatric (p = 0.024) group were similarly found to be impaired in the Digit Span Backward relative to healthy controls, however no differences were seen between the patient groups. The findings indicate that contour integration deficits are not specific to schizophrenia spectrum disorders, and instead the neurobiological underpinnings of visual integration impairment may share commonality with psychosis more generally. The findings are also consistent with cognitive factors playing a potential role in JOVI performance and highlight the difficulty in teasing apart altered perceptual and cognitive function in psychiatric patient groups.
- 9 April 2025
- Published by Springer Nature in Schizophrenia
- Vol. 11 (1) , 1-9
Open AccessVisual integration deficits associated with psychosis are independent of diagnosis
Evidence of altered visual processing is well‐established in schizophrenia. Visual integration deficits have been highlighted as a potential diagnostic biomarker to distinguish schizophrenia from other psychiatric disorders. Motivated by the current lack of cross-diagnostic assessments of visual integration performance, the current study used the Jittered Orientation Visual Integration (JOVI) task to assess contour integration performance in 85 psychiatric inpatients split into “schizophrenia spectrum” (n = 40) and “other psychiatric disorders” (n = 45), and healthy controls (n = 43). The study also examined attentional and working memory ability using the Digit Span Task. JOVI accuracy scores were found to be significantly impaired relative to healthy controls for both the schizophrenia (p < 0.001) and other psychiatric (p < 0001) patient groups. In line with a transdiagnostic deficit, no differences in JOVI accuracy were seen between the patient groups (p = 0.97) with reduced JOVI accuracy correlating with worsening psychosis regardless of diagnosis (r = −0.32, p < 0.05). Schizophrenia spectrum patients also showed reduced Digit Span Forward (p < 0.001) and Backward scores (p < 0.001). The other psychiatric (p = 0.024) group were similarly found to be impaired in the Digit Span Backward relative to healthy controls, however no differences were seen between the patient groups. The findings indicate that contour integration deficits are not specific to schizophrenia spectrum disorders, and instead the neurobiological underpinnings of visual integration impairment may share commonality with psychosis more generally. The findings are also consistent with cognitive factors playing a potential role in JOVI performance and highlight the difficulty in teasing apart altered perceptual and cognitive function in psychiatric patient groups.
- Open Access
- 18 December 2024
- Published by Springer Nature in Research Square
Differential effects of NMDAR antagonists on working memory and gamma oscillations, and the mediating role of the GluN2D subunit
Working memory relies on synchronised network oscillations involving complex interplay between pyramidal cells and GABAergic interneurons. NMDA receptor (NMDAR) antagonists influence both network oscillations and working memory, but the relationship between these two consequences has not been elucidated. This study aimed to determine the effect of NMDAR antagonists on network oscillations during a working memory task in mice, and the contribution of the GluN2D receptor subunit. After training wildtype (WT) and GluN2D-knockout (KO) mice on the Trial-Unique-Non-match to Location (TUNL) touchscreen task of working memory, recording electrodes were implanted into the prefrontal cortex (PFC) and hippocampus. Mice were challenged with either (S)-ketamine (30mg/kg), (R)-ketamine (30mg/kg), phencyclidine (PCP, 1mg/kg), MK-801 (0.3mg/kg) or saline prior to TUNL testing while simultaneous local field potential recordings were acquired. PCP disrupted working memory accuracy in WT (p=0.001) but not GluN2D-KO mice (p=0.79). MK-801 (p<0.0001), (S)-ketamine (p<0.0001) and (R)-ketamine (p=0.007) disrupted working memory accuracy in both genotypes. PCP increased baseline gamma (30-80Hz) power in the hippocampus in WT (p=0.0015) but not GluN2D-KO mice (p=0.92). All drugs increased baseline gamma power in the PFC in both genotypes (p<0.05). Low gamma was induced during the maintenance phase of the TUNL task and increased when mice correctly completed the task (p=0.024). MK-801 disrupted task-induced low gamma in both genotypes (p=0.04). In summary, PCP action involves the GluN2D subunit of the NMDA receptor in the hippocampus to alter baseline gamma power and working memory. Task-induced low gamma activity during maintenance aligns with task performance, and is disrupted specifically by MK-801.
- 18 December 2024
- Published by Springer Nature in Research Square
Open AccessDifferential effects of NMDAR antagonists on working memory and gamma oscillations, and the mediating role of the GluN2D subunit
Working memory relies on synchronised network oscillations involving complex interplay between pyramidal cells and GABAergic interneurons. NMDA receptor (NMDAR) antagonists influence both network oscillations and working memory, but the relationship between these two consequences has not been elucidated. This study aimed to determine the effect of NMDAR antagonists on network oscillations during a working memory task in mice, and the contribution of the GluN2D receptor subunit. After training wildtype (WT) and GluN2D-knockout (KO) mice on the Trial-Unique-Non-match to Location (TUNL) touchscreen task of working memory, recording electrodes were implanted into the prefrontal cortex (PFC) and hippocampus. Mice were challenged with either (S)-ketamine (30mg/kg), (R)-ketamine (30mg/kg), phencyclidine (PCP, 1mg/kg), MK-801 (0.3mg/kg) or saline prior to TUNL testing while simultaneous local field potential recordings were acquired. PCP disrupted working memory accuracy in WT (p=0.001) but not GluN2D-KO mice (p=0.79). MK-801 (p<0.0001), (S)-ketamine (p<0.0001) and (R)-ketamine (p=0.007) disrupted working memory accuracy in both genotypes. PCP increased baseline gamma (30-80Hz) power in the hippocampus in WT (p=0.0015) but not GluN2D-KO mice (p=0.92). All drugs increased baseline gamma power in the PFC in both genotypes (p<0.05). Low gamma was induced during the maintenance phase of the TUNL task and increased when mice correctly completed the task (p=0.024). MK-801 disrupted task-induced low gamma in both genotypes (p=0.04). In summary, PCP action involves the GluN2D subunit of the NMDA receptor in the hippocampus to alter baseline gamma power and working memory. Task-induced low gamma activity during maintenance aligns with task performance, and is disrupted specifically by MK-801.